Annual report pursuant to Section 13 and 15(d)

Concentration of Risk

Concentration of Risk

12 Months Ended

Nov. 30, 2017

Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada.

During the fiscal years ended November 30, 2017, 2016 and 2015, certain customers each accounted for more than 5% of the Company’s net sales, as follows:



	For the Year Ended November 30,
Customer	2017		2016		2015
Walmart	36.3	%	38.7	%	34.6	%
Walgreens	13.4	%	10.5	%	13.4	%
Target	6.9	%	8.6	%	7.2	%
CVS	*		*		5.7	%
Foreign Sales	12.4	%	11.3	%	13.2	%



*	less than 5%

The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position.

During the fiscal years November 30, 2017, 2016 and 2015, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows:



	For the Year Ended November 30,
Category	2017		2016		2015
Skin Care	52.6	%	54.0	%	51.9	%
Oral Care	37.8	%	38.7	%	34.4	%